Assessing the quality of reporting in artificial intelligence/machine learning research for cardiac amyloidosis
{{output}}
Objectives: Despite the rapid development of AI in clinical medicine, reproducibility and methodological limitations hinder its clinical utility. In response, MINimum Information for Medical AI Reporting (MINIMAR) standards were ... ...
